A study was undertaken to investigate the effects of oxypertine in treating tardive dyskinesia. The design was double-blind, placebo-controlled, between-patient, in 28 patients from whom previous medication was withdrawn, with 14 patients in each group. Treatment was for 4 weeks. Although more oxypertine patients improved than placebo, i.e. 71.4 vs. 50%, the results did not reach statistically significant difference. A further study is planned to increase the overall number of patients in the study, and to lengthen treatment periods.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1159/000468451 | DOI Listing |
Publication Analysis
Top Keywords
tardive dyskinesia
8
controlled trial
4
trial oxypertine
4
oxypertine tardive
4
dyskinesia study
4
study undertaken
4
undertaken investigate
4
investigate effects
4
effects oxypertine
4
oxypertine treating
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!